Jan de Witte - 11 Mar 2024 Form 4 Insider Report for INTEGRA LIFESCIENCES HOLDINGS CORP (IART)

Reporting relationship: President & CEO, Director
Issuer ticker: IART
Reported as of: 11 Mar 2024
Net transaction value: -$7,425
SEC form: 4
Accepted by SEC: 13 Mar 2024, 16:30:35 UTC
Prior SEC filing: 12 Mar 2024
Next SEC filing: 22 May 2024
Source filing: View source filing
Reporting owner signature: /s/ Eric Schwartz; Attorney-in-Fact

Key filing fact

Jan de Witte filed Form 4 for INTEGRA LIFESCIENCES HOLDINGS CORP (IART) on 13 Mar 2024.

Key facts

This page summarizes Jan de Witte's Form 4 filing for INTEGRA LIFESCIENCES HOLDINGS CORP (IART).
5 reported transactions and 3 derivative rows are listed below.
Accepted by SEC: 13 Mar 2024, 16:30.

Change

Previous filing in this sequence was filed on 12 Mar 2024.
Current net transaction value: -$7,425.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

IART transaction

Common Stock

Options Exercise

Transaction value: $0
Shares: +205
Change %: +1.1%
Price: $0.000000
Shares after: 18,555
Date: 11 Mar 2024
Ownership: Direct

IART transaction

Common Stock

Tax liability

Transaction value: $7,425
Shares: -205
Change %: -1.1%
Price: $36.22
Shares after: 18,350
Date: 11 Mar 2024
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

IART transaction Derivative

Non- Qualified Stock Option (right to buy)

Award

Transaction value: $0
Shares: +95,664
Change %
Price: $0.000000
Shares after: 95,664
Date: 11 Mar 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 95,664
Exercise price: $36.22
Footnotes: F1

IART transaction Derivative

Restricted Stock Units

Award

Transaction value: $0
Shares: +41,414
Change %: +46%
Price: $0.000000
Shares after: 130,485
Date: 11 Mar 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 41,414
Exercise price: $0.000000
Footnotes: F2

IART transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value: $0
Shares: -205
Change %: -0.16%
Price: $0.000000
Shares after: 130,280
Date: 11 Mar 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 205
Exercise price: $0.000000
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

25% of the stock options vest every first, second, third and fourth anniversaries of the grant date of 3/11/2024.

Footnote F2

The award was a restricted stock unit award which will vest in three equal annual installments on the first, second and third anniversaries of the grant date of 3/11/2024 which shall be delivered to Mr. De Witte within 30 days following the first business day that occurs immediately following the six month period after the date of his separation of service as deferred compensation. The award is subject to accelerated vesting upon termination of employment by reason of death or disability or upon a qualifying termination on or within 24 months following the date of a change in control.

Footnote F3

The award was a restricted stock unit award which will vest in three equal annual installments on the first, second and third anniversaries of the grant date of 3/11/2022 of which the second installment vested on 3/11/2024 and which shall be delivered to Mr. De Witte within 30 days following the first business day that occurs immediately following the six-month period after the date of his separation of service as deferred compensation.